Sort   by:  
 Page size 
TranscriptomicsBortezomib inhibits mTOR pathway in multiple myeloma cells via induced expression of REDD1.
The combination of bortezomib and dexamethasone should become the reference induction treatment for multiple myeloma patients younger than 65 years. Pharmacogenomic profiles of genes involved in response to treatment may help to understand resistance. We performed gene expression profiling in 9 myel...
ORGANISM(S): Homo sapiens 
2010-02-14 | E-GEOD-11866 | biostudies-arrayexpress
TranscriptomicsGenetic adaptability of cancer cells under treatment selection pressure in multiple myeloma patients.
Purpose Despite advances and significant improvement in survival, multiple myeloma (MM) remains incurable and nearly all patients relapse after treatment. Previous studies have shown a complex spectrum of diverse genetic alterations in almost all patients, but evolution of genomic rearrangements th...
ORGANISM(S): Homo sapiens 
2013-02-13 | E-GEOD-25262 | biostudies-arrayexpress
TranscriptomicsExpression of genetic adaptability of cancer cells under treatment selection pressure in multiple myeloma patients
Series GSE25262 patients on expression side. [Exon study] 11 myeloma patients at diagnosis and relapse examined with Exon expression chip
ORGANISM(S): Homo sapiens 
2013-02-13 | E-GEOD-37414 | biostudies-arrayexpress
TranscriptomicsMinor clone provides a reservoir for relapse in multiple myeloma
In this study we addressed subclonal evolutionary process after treatment and subsequent relapse in multiple myeloma (MM) in a cohort of 24 MM patients treated either with conventional chemotherapy or with the proteasome inhibitor, bortezomib. Because MM is a highly heterogeneous disease coupled wit...
ORGANISM(S): Homo sapiens 
2013-02-13 | E-GEOD-37469 | biostudies-arrayexpress
UnknownHow to quantify monoclonal free light chains in plasma cell disorders: which mass spectrometry technology?
Not available
S-EPMC7475393 | biostudies-literature
UnknownRole of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.
Not available
S-EPMC5894960 | biostudies-literature
UnknownIntensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury.
Not available
S-EPMC5887381 | biostudies-literature
UnknownCharacteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1.
Not available
S-EPMC7281552 | biostudies-literature
UnknownDiagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.
Not available
S-EPMC5896069 | biostudies-literature
UnknownComparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens.
Not available
S-EPMC7922508 | biostudies-literature
Sort   by:  
 Page size